Annual report pursuant to Section 13 and 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.21.2
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Revenue, Major Customer [Line Items]    
Revenues $ 61,259,528 $ 42,592,060
FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 60,396,697 40,556,818
PREBOOST Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 862,831 2,035,242
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 46,470,448 27,124,462
Global Public Health Sector [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues $ 13,926,249 $ 13,432,356